Ondrejcak T - Search Results

1

Do tau-synaptic long-term depression interactions in the hippocampus play a pivotal role in the progression of Alzheimer's disease?

Hu Z, Ondrejcak T, Yu P, Zhang Y, Yang Y, Klyubin I, Kennelly SP, Rowan MJ, Hu NW. Hu Z, et al. Among authors: ondrejcak t. Neural Regen Res. 2023 Jun;18(6):1213-1219. doi: 10.4103/1673-5374.360166. Neural Regen Res. 2023. PMID: 36453396 Free PMC article. Review.

2

Ischemic preconditioning does not improve neurological recovery after spinal cord compression injury in the rat.

Ondrejcák T, Vanický I, Gálik J. Ondrejcák T, et al. Brain Res. 2004 Jan 9;995(2):267-73. doi: 10.1016/j.brainres.2003.10.009. Brain Res. 2004. PMID: 14672817

3

Alzheimer's disease amyloid beta-protein and synaptic function.

Ondrejcak T, Klyubin I, Hu NW, Barry AE, Cullen WK, Rowan MJ. Ondrejcak T, et al. Neuromolecular Med. 2010 Mar;12(1):13-26. doi: 10.1007/s12017-009-8091-0. Epub 2009 Sep 16. Neuromolecular Med. 2010. PMID: 19757208 Review.

4

Removal of synaptic Ca²+-permeable AMPA receptors during sleep.

Lanté F, Toledo-Salas JC, Ondrejcak T, Rowan MJ, Ulrich D. Lanté F, et al. Among authors: ondrejcak t. J Neurosci. 2011 Mar 16;31(11):3953-61. doi: 10.1523/JNEUROSCI.3210-10.2011. J Neurosci. 2011. PMID: 21411638 Free PMC article.

5

Glutamate receptors in preclinical research on Alzheimer's disease: update on recent advances.

Hu NW, Ondrejcak T, Rowan MJ. Hu NW, et al. Among authors: ondrejcak t. Pharmacol Biochem Behav. 2012 Feb;100(4):855-62. doi: 10.1016/j.pbb.2011.04.013. Epub 2011 Apr 22. Pharmacol Biochem Behav. 2012. PMID: 21536064 Review.

6

Activation of α7 nicotinic acetylcholine receptors persistently enhances hippocampal synaptic transmission and prevents Aß-mediated inhibition of LTP in the rat hippocampus.

Ondrejcak T, Wang Q, Kew JN, Virley DJ, Upton N, Anwyl R, Rowan MJ. Ondrejcak T, et al. Eur J Pharmacol. 2012 Feb 29;677(1-3):63-70. doi: 10.1016/j.ejphar.2011.12.008. Epub 2011 Dec 16. Eur J Pharmacol. 2012. PMID: 22200627

7

Neurotransmitter receptor and time dependence of the synaptic plasticity disrupting actions of Alzheimer's disease Aβ in vivo.

Klyubin I, Ondrejcak T, Hayes J, Cullen WK, Mably AJ, Walsh DM, Rowan MJ. Klyubin I, et al. Among authors: ondrejcak t. Philos Trans R Soc Lond B Biol Sci. 2013 Dec 2;369(1633):20130147. doi: 10.1098/rstb.2013.0147. Print 2014 Jan 5. Philos Trans R Soc Lond B Biol Sci. 2013. PMID: 24298149 Free PMC article.

8

A human monoclonal IgG that binds aβ assemblies and diverse amyloids exhibits anti-amyloid activities in vitro and in vivo.

Levites Y, O'Nuallain B, Puligedda RD, Ondrejcak T, Adekar SP, Chen C, Cruz PE, Rosario AM, Macy S, Mably AJ, Walsh DM, Vidal R, Solomon A, Brown D, Rowan MJ, Golde TE, Dessain SK. Levites Y, et al. Among authors: ondrejcak t. J Neurosci. 2015 Apr 22;35(16):6265-76. doi: 10.1523/JNEUROSCI.5109-14.2015. J Neurosci. 2015. PMID: 25904780 Free PMC article.

9

Opposite in vivo effects of agents that stimulate or inhibit the glutamate/cysteine exchanger system xc- on the inhibition of hippocampal LTP by Aß.

Zhang D, Jin B, Ondrejcak T, Rowan MJ. Zhang D, et al. Among authors: ondrejcak t. Hippocampus. 2016 Dec;26(12):1655-1665. doi: 10.1002/hipo.22667. Epub 2016 Oct 18. Hippocampus. 2016. PMID: 27701797

10

Targeting glutamatergic and cellular prion protein mechanisms of amyloid β-mediated persistent synaptic plasticity disruption: Longitudinal studies.

Zhang D, Qi Y, Klyubin I, Ondrejcak T, Sarell CJ, Cuello AC, Collinge J, Rowan MJ. Zhang D, et al. Among authors: ondrejcak t. Neuropharmacology. 2017 Jul 15;121:231-246. doi: 10.1016/j.neuropharm.2017.03.036. Epub 2017 Apr 5. Neuropharmacology. 2017. PMID: 28390893 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page